• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾细胞癌保肾手术后切缘宽度的预后重要性。

Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma.

作者信息

Castilla Elias A, Liou Louis S, Abrahams Neil A, Fergany Amr, Rybicki Lisa A, Myles Jonathan, Novick Andrew C

机构信息

Department of Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

出版信息

Urology. 2002 Dec;60(6):993-7. doi: 10.1016/s0090-4295(02)01983-0.

DOI:10.1016/s0090-4295(02)01983-0
PMID:12475656
Abstract

OBJECTIVES

To examine the relationship between the width of the resection margin and disease progression in renal cell carcinoma (RCC) after nephron-sparing surgery (NSS). During NSS for RCC, it is standard practice to excise the tumor along with a surrounding margin of normal parenchyma (margin of resection) to ensure complete resection of the neoplasm. However, no agreement has been reached on how wide the margin of resection should be.

METHODS

We retrospectively reviewed the histopathologic sections and medical records of 69 patients with localized RCC who had undergone NSS between 1976 and 1988 to determine whether the resection margin, tumor size, TNM stage, and Fuhrman nuclear grade were associated with disease progression (defined as local tumor recurrence or metastasis). The mean postoperative follow-up interval was 8.5 years.

RESULTS

No association was found between the width of the resection margin and disease progression (P = 0.98, log-rank test). Both TNM stage and Fuhrman nuclear grade correlated with disease progression. Patients with T1-T2 tumors had lower progression (P <0.001, log-rank test), and increased Fuhrman nuclear grade correlated with more disease progression (P <0.001, log-rank test).

CONCLUSIONS

The width of the resection margin after NSS for RCC does not correlate with long-term disease progression. A histologic tumor-free margin of resection, irrespective of the width of the margin is sufficient to achieve complete local excision of RCC.

摘要

目的

探讨保留肾单位手术(NSS)治疗肾细胞癌(RCC)后切缘宽度与疾病进展之间的关系。在对RCC进行NSS时,标准做法是切除肿瘤及其周围正常实质边缘(切缘),以确保肿瘤完全切除。然而,对于切缘应多宽尚未达成共识。

方法

我们回顾性分析了1976年至1988年间接受NSS的69例局限性RCC患者的组织病理学切片和病历,以确定切缘、肿瘤大小、TNM分期和Fuhrman核分级是否与疾病进展(定义为局部肿瘤复发或转移)相关。术后平均随访时间为8.5年。

结果

未发现切缘宽度与疾病进展之间存在关联(P = 0.98,对数秩检验)。TNM分期和Fuhrman核分级均与疾病进展相关。T1-T2期肿瘤患者的疾病进展率较低(P <0.001,对数秩检验),Fuhrman核分级增加与疾病进展增加相关(P <0.001,对数秩检验)。

结论

RCC患者NSS后的切缘宽度与长期疾病进展无关。无论切缘宽度如何,无肿瘤组织学切缘足以实现RCC的完全局部切除。

相似文献

1
Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma.肾细胞癌保肾手术后切缘宽度的预后重要性。
Urology. 2002 Dec;60(6):993-7. doi: 10.1016/s0090-4295(02)01983-0.
2
Impact of resection margin status after nephron-sparing surgery for renal cell carcinoma.肾细胞癌保肾手术后切缘状态的影响
BJU Int. 2006 Jun;97(6):1208-10. doi: 10.1111/j.1464-410X.2006.06157.x.
3
Routine frozen-section biopsy from the surgical bed should be performed during nephron-sparing surgery for renal cell carcinoma.对于肾细胞癌的保留肾单位手术,应在手术床进行常规冰冻切片活检。
Scand J Urol Nephrol. 2005;39(3):222-5. doi: 10.1080/00365590510007757.
4
Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.选择性保留肾单位手术应成为小的单侧肾细胞癌的标准治疗方法:216例患者的长期生存数据。
Eur Urol. 2006 Feb;49(2):308-13. doi: 10.1016/j.eururo.2005.10.020. Epub 2005 Dec 9.
5
Is a 1-CM margin necessary during nephron-sparing surgery for renal cell carcinoma?肾细胞癌保留肾单位手术时,1厘米的切缘是否必要?
Urology. 2001 Dec;58(6):849-52. doi: 10.1016/s0090-4295(01)01393-0.
6
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.肾细胞癌的保留肾单位手术:预测患者预后的临床病理特征
Urology. 2003 Oct;62(4):641-6. doi: 10.1016/s0090-4295(03)00489-8.
7
A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.一项前瞻性、随机、EORTC 多组间 3 期研究比较了选择性保留肾单位手术和根治性肾切除术治疗低分期肾细胞癌的肿瘤学结局。
Eur Urol. 2011 Apr;59(4):543-52. doi: 10.1016/j.eururo.2010.12.013. Epub 2010 Dec 22.
8
Oncologic Impact of Renal Tissue Adjacent to Renal Cell Carcinoma.肾细胞癌旁肾组织的肿瘤学影响
Anticancer Res. 2016 Jun;36(6):2865-9.
9
Outcome of nephron-sparing surgery for T1b renal cell carcinoma.T1b期肾细胞癌保留肾单位手术的疗效
BJU Int. 2009 May;103(10):1344-8. doi: 10.1111/j.1464-410X.2008.08230.x. Epub 2008 Nov 25.
10
Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.单侧肾细胞癌且对侧肾脏正常患者行根治性肾切除术与保留肾单位手术的配对比较。
Mayo Clin Proc. 2000 Dec;75(12):1236-42. doi: 10.4065/75.12.1236.

引用本文的文献

1
Recommendations and optimal approaches to robotic-assisted partial nephrectomy: A consensus of Brazilian experts.机器人辅助部分肾切除术的推荐意见及最佳方法:巴西专家共识
Front Urol. 2023 Feb 3;3:1119494. doi: 10.3389/fruro.2023.1119494. eCollection 2023.
2
Comparing the oncologic outcomes of local tumor destruction vs. local tumor excision vs. partial nephrectomy in T1a solid renal masses: a population-based cohort study from the SEER database.比较 T1a 期实体性肾肿瘤中局部肿瘤破坏、局部肿瘤切除与部分肾切除术的肿瘤学结局:来自 SEER 数据库的一项基于人群的队列研究。
Int J Surg. 2024 Aug 1;110(8):4571-4580. doi: 10.1097/JS9.0000000000001465.
3
Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic Review.
肾门部肿块的机器人辅助部分肾切除术(RAPN)的结果与技术:一项全面的系统评价
Cancers (Basel). 2024 Feb 6;16(4):693. doi: 10.3390/cancers16040693.
4
Robotic-assisted tumor enucleation versus robotic-assisted partial nephrectomy for intermediate and high complexity renal cell carcinoma: a single-institution experience.机器人辅助肿瘤剜除术与机器人辅助部分肾切除术治疗中高危复杂性肾细胞癌:单中心经验。
World J Surg Oncol. 2023 Jun 8;21(1):175. doi: 10.1186/s12957-023-03060-3.
5
Resection Techniques During Robotic Partial Nephrectomy: A Systematic Review.机器人辅助部分肾切除术的切除技术:一项系统评价
Eur Urol Open Sci. 2023 Apr 29;52:7-21. doi: 10.1016/j.euros.2023.03.008. eCollection 2023 Jun.
6
Tumor enucleation for the treatment of T1 renal tumors: A systematic review and meta-analysis.肿瘤剜除术治疗 T1 期肾肿瘤:系统评价和荟萃分析。
Investig Clin Urol. 2022 Mar;63(2):126-139. doi: 10.4111/icu.20210361.
7
Trifecta outcomes of modified robot-assisted simple enucleation and standard robot-assisted partial nephrectomy for treating clinical T1b renal cell carcinoma.改良机器人辅助单纯剜除术与标准机器人辅助部分肾切除术治疗临床T1b期肾细胞癌的三联预后
Transl Androl Urol. 2021 Mar;10(3):1080-1087. doi: 10.21037/tau-20-1153.
8
Open partial nephrectomy: current review.开放性部分肾切除术:当前综述
Transl Androl Urol. 2020 Dec;9(6):3149-3159. doi: 10.21037/tau-20-474.
9
The Clinicopathological Risk Factors in Renal Cell Cancer for the Oncological Outcomes Following Nephron-Sparing Surgery: A PRISMA Systematic Review and Meta-Analysis.肾部分切除术后肾细胞癌肿瘤学结局的临床病理危险因素:一项PRISMA系统评价和Meta分析
Front Oncol. 2020 Mar 6;10:286. doi: 10.3389/fonc.2020.00286. eCollection 2020.
10
Augmented reality in a tumor resection model.增强现实在肿瘤切除模型中的应用。
Surg Endosc. 2018 Mar;32(3):1192-1201. doi: 10.1007/s00464-017-5791-7. Epub 2017 Aug 15.